MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0019961
Curezen Pharma Private Limited - pharma in Secunderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.51 Cr
▲ 16% YoY
Net profit · FY 2025
₹21.05 Lakh
Net margin 3.2%
EBITDA · FY 2025
₹25.51 Lakh
EBITDA margin 3.9%
Authorised capital
₹75 Lakh
Registered with MCA
Paid-up capital
₹75 Lakh
Issued & subscribed
Open charges
₹25 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
3
As per MCA filings
About Curezen Pharma Private Limited
Data last updated:
Curezen Pharma Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2016PTC110785. Its GSTIN is 36AAGCC5429C1ZW (Telangana).
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹75 Lakh. It is led by directors including Raja Narender Madaboina and Madhumathi Kulkarni.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 2/A North Portion Ground Floor Vijay Nagar Colony Picket, Secunderabad, Telangana, India – 500026.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.51 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹21.05 Lakh (net margin 3.2%) and EBITDA of ₹25.51 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 26% over five years.
As per MCA filings, the company has open charges of ₹25 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
Curezen Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0019961). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website curezen.com.
Company details
CIN U24230TG2016PTC110785
Registration Number 110785
Incorporation Date 09 July 2016
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0019961
Key People
Raja Narender Madaboina Director Madhumathi Kulkarni Director Vani Rajkumar Kulkarni Director Recognitions & Rankings of Curezen Pharma
Contact details
Curezen Pharma Private Limited's registered office is in Secunderabad, Telangana. Its website is curezen.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 2/A North Portion Ground Floor Vijay Nagar Colony Picket, Secunderabad, Telangana, India – 500026
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Curezen Pharma Private Limited, buy the company report.
Comprehensive company report
Curezen Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Curezen Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Curezen Pharma Private Limited, buy the company report.
Financials of Curezen Pharma Private Limited
FY 2025 filings availableCurezen Pharma Private Limited reported revenue of ₹6.51 Cr (up 16% YoY) for FY 2025.
Revenue · FY 2025
₹6.51 Cr ▲ 16%
Net profit · FY 2025
₹21.05 Lakh margin 3.2%
EBITDA · FY 2025
₹25.51 Lakh margin 3.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 22%
5 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 47%
5 years · compounded
▲ 38%
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 16% growth in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25.51 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Curezen Pharma Private Limited, buy the company report.
Board of directors of Curezen Pharma Private Limited
Curezen Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raja Narender Madaboina | Director | 09 Jul 2016 | 10 Years 3 Months | Current |
| Madhumathi Kulkarni | Director | 09 Jul 2016 | 10 Years 3 Months | Current |
| Vani Rajkumar Kulkarni Also directs: Achala Remedies LLP | Director | 09 Jul 2016 | 10 Years 3 Months | Current |
Peer comparison
Curezen Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| F & G Supply Private Limited | ₹6.52 Cr (FY 2025) | 47.0% | Delhi, India | |||
| Maharshi Industries Private Limited | ₹6.52 Cr (FY 2025) | 43.0% | Gujarat, India | |||
| Heartlink Medical Solutions Private Limited | ₹6.52 Cr (FY 2025) | 108.0% | Kolkata, West Bengal, India | |||
| Ceramic City Private Limited | ₹6.52 Cr (FY 2024) | 3.0% | Kolkata, West Bengal, India | |||
| Artlife Wellness Products Private Limited | ₹6.51 Cr (FY 2024) | -20.0% | New Delhi, Delhi, India | |||
| Curezen Pharma Private Limitedthis company | ₹6.51 Cr (FY 2025) | ₹21.05 Lakh | 3.2% | 16.0% | Secunderabad, Telangana, India | |
| Skincare Surgipharma Private Limited | ₹6.51 Cr (FY 2024) | -3.0% | Mumbai, Maharashtra, India | |||
| Salt Lake Wine Pvt Ltd | ₹6.51 Cr (FY 2023) | 4.0% | Kolkata, West Bengal, India | |||
| New Light Electricals Private Limited | ₹6.51 Cr (FY 2025) | 0.0% | Chandigarh, India | |||
| Samir Automobiles Private Limited | ₹6.51 Cr (FY 2020) | 47.0% | Guwahati, Assam, India | |||
| RB Assets & Developers Private Limited | ₹6.51 Cr (FY 2025) | -37.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Curezen Pharma Private Limited, buy the company report.
Auditor
Curezen Pharma Private Limited is audited by M. MAHENDER REDDY & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M. MAHENDER REDDY & CO | FY 2023 | 237393 |
Shareholding
The shareholding of Curezen Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Curezen Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹25 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jan 2018 | 100160012 | City Union Bank Limited | ₹25 Lakh | Open |
To see the full charge records of Curezen Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Curezen Pharma Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad Central, Telangana | Criminal complaint | Filed against the company by The State of Telangana Rep by the Drugs Inspector, Secunderabad | Disposed |
To see the full case history of Curezen Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Curezen Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Curezen Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCC5429C1ZW | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Curezen Pharma Private Limited, buy the company report.
Recent activity
Curezen Pharma Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Madhumathi Kulkarni was appointed as Director on 09 Jul 2016.
AGM
Curezen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Curezen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with City Union Bank Limited of Rs. 25.00 Lakh registered on 23 Jan 2018 with Charge ID 100160012 was modified on 15 Mar 2019.
Charges
A charge with City Union Bank Limited amounted to Rs. 25.00 Lakh with Charge ID 100160012 was registered on 23 Jan 2018.
Appointed
Madhumathi Kulkarni was appointed as Director.
Appointed
Raja Narender Madaboina was appointed as Director.
Appointed
Vani Rajkumar Kulkarni was appointed as Director.
Incorporation
09 Jul 2016
Curezen Pharma Private Limited was registered on 09 Jul 2016 with Roc Hyderabad & aged 10 years 3 months as per MCA records.
Frequently asked questions
Curezen Pharma is an active private limited company based in Secunderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 July 2016 (10+ years old) and is registered under CIN U24230TG2016PTC110785.
Curezen Pharma has 3 current directors:
- Raja Narender Madaboina - Director
- Madhumathi Kulkarni - Director
- Vani Rajkumar Kulkarni - Director
The latest financial statements of Curezen Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Curezen Pharma is 36AAGCC5429C1ZW, registered in Telangana.
The CIN (Corporate Identification Number) of Curezen Pharma is U24230TG2016PTC110785. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curezen Pharma has 1 court case on record: 1 filed against it.
Curezen Pharma was incorporated on 09 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Curezen Pharma by revenue are F & G Supply Private Limited, Maharshi Industries Private Limited, Heartlink Medical Solutions Private Limited, Ceramic City Private Limited, Artlife Wellness Products Private Limited and 5 more, all in the same principal business activity (retail trading).
Madhumathi Kulkarni was appointed as Director on 09 Jul 2016. Raja Narender Madaboina was appointed as Director on 09 Jul 2016. Vani Rajkumar Kulkarni was appointed as Director on 09 Jul 2016.
Yes, Curezen Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0019961).
Curezen Pharma can be reached through the website curezen.com. Its registered office is in Secunderabad, Telangana, India.